5.89% More Viveve Medical Inc (NASDAQ:VIVE) Shares Shorted

June 27, 2018 - By Don Salinas

Viveve Medical Inc (NASDAQ:VIVE) noted an increase of 5.89% in shares shorted. FINRA issued in June VIVE’s total 3.33M shares shorted. The up change of 5.89% from 3.14 million shares was reported. Viveve Medical Inc (NASDAQ:VIVE) has 281,800 shares average volume. It’ll cost 12 days for VIVE to recover its former position. Viveve Medical Inc float short is 37.34%.

VIVE reached $2.75 during the last trading session after $0.02 change.Currently Viveve Medical, Inc. is downtrending after 65.48% change in last June 27, 2017. VIVE has also 152,786 shares volume. VIVE underperformed by 78.05% the S&P 500.

Viveve Medical, Inc. designs, develops, makes, and markets medical devices for the non-invasive treatment of vaginal laxity.The firm is valued at $85.99 million. The firm offers Geneveve, a non-invasive solution that includes the Viveve System, a radio frequency generator; a reusable hand piece and single-use treatment tip; and other consumable accessories.Last it reported negative earnings. It markets its products through sales employees and distributors in Asia, Europe, the Middle East, Latin America, the United States, Canada, and internationally.

For more Viveve Medical, Inc. (NASDAQ:VIVE) news brought out briefly go to: Streetinsider.com, Benzinga.com, Globenewswire.com, Seekingalpha.com or Globenewswire.com. The titles are as follows: “After-Hours Stock Movers 06/18: (GEVO) (VIVE) (CL) Higher; (PAGS) (TELL) (DEA) Lower (more…)” brought out on June 18, 2018, “5 Stocks Moving In Monday’s After-Hours Session” on June 19, 2018, “Viveve to Present at Jefferies Global Healthcare Conference” with a publish date: May 29, 2018, “Viveve Medical’s CMRF technology shows positive effect in women with SUI; shares up 12% after hours” and the last “Viveve Announces Settlement of Patent Infringement Litigation with Thermi” with publication date: June 04, 2018.

Viveve Medical, Inc. (NASDAQ:VIVE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: